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Abstract
Background: Human pythiosis is an emerging and life-threatening infectious disease caused by Pythium
insidiosum. It occurs primarily in tropical, subtropical and temperate areas of the world, including Thailand. The aim
of this report is to present the first pediatric case of typical vascular pythiosis.
Case Presentation: A 10-year-old boy with underlying b-thalassemia presented with gangrenous ulcers and
claudication of the right leg which were unresponsive to antibiotic therapy for 6 weeks. Computerized tomography
angiography indicated chronic arterial occlusion involving the right distal external iliac artery and its branches.
High-above-knee amputation was urgently done to remove infected arteries and tissues, and to stop disease
progression. Antibody to P. insidiosum was detected in a serum sample by the immunoblot and the
immunochromatography tests. Fungal culture followed by nucleic sequence analysis was positive for P. insidiosum
in the resected iliac arterial tissue. Immunotherapeutic vaccine and antifungal agents were administered. The
patient remained well and was discharged after 2 months hospitalization without recurrence of the disease. At the
time of this communication he has been symptom-free for 2 years.
Conclusions: The child presented with the classical manifestations of vascular pythiosis as seen in adult cases.
However, because pediatricians were unfamiliar with the disease, diagnosis and surgical treatment were delayed.
Both early diagnosis and appropriate surgical and medical treatments are crucial for good prognosis.
Background
Pythiosis is a life-threatening infectious disease occur-
ring in humans and animals. The etiologic agent of the
disease is Pythium insidiosum, an aquatic fungus-like
organism (kingdom Chromista, phylum Oomycota, class
Oomycetes), having an ecologic preference for swampy
areas and found primarily in tropical, subtropical and
temperate areas of the world [1-3].
Human pythiosis was first reported from Thailand in
1985 [4]. There are 4 different clinical forms of human
pythiosis: vascular, ocular, cutaneous/subcutaneous and
miscellaneous forms which account for 59, 33, 5, and
3% of all reported cases, respectively. All except the ocu-
lar form have been associated with patients who have
underlying hematological diseases [2,3,5]. Human
pythiosis is rare in children. Only a few well-documen-
ted cases have been reported, all of which were the
cutaneous/subcutaneous form [6-8]. Human pythiosis
has significant morbidity and mortality [2-5] because
clinical information and diagnostic tools are limited,
leading to under-recognition and under-diagnosis of the
disease. Both early diagnosis and appropriate treatment
are crucial for good prognosis. In this report, we
described the first case of typical vascular pythiosis in a
child in whom therapy was successful.
Case presentation
A 10-year-old boy who had had a splenectomy for his
underlying b-thalassemia was admitted to the Chiang
Mai University (CMU) Hospital for a gangrenous ulcer
on his right leg and claudication. Six weeks prior to
admission, he first noticed a small pustular lesion on his
right ankle which later spontaneously ruptured and
became an ulcer. There was no previous history of
trauma. The patient reported frequently working in a
rice field with his parents. He was brought to a local
hospital where the diagnosis of pyomyositis was made.
Incision and drainage were performed and his symptoms
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improved. Two weeks prior to admission another pustu-
lar lesion developed on his right shin which finally
became a gangrenous ulcer. His other symptoms were
fever, severe resting pain, intermittent claudication and
swollen right knee. He was transferred to a district hos-
pital where an ultrasound showed thrombosis of the
right femoral and popliteal artery and enlarged lymph
nodes at the right popliteal fossa. Arthrocentesis of the
right knee revealed 855,000 cells/mm3 of WBC (poly-
morphonuclear cell 74%, mononuclear cell 26%). He
was diagnosed as having septic arthritis. Intravenous
cloxacillin was given and the patient was transferred to
the CMU Hospital.
Physical examination at the CMU Hospital revealed old
ulcerated scars on the right shin and ankle (Figure 1),
marked tenderness along the right leg, cool skin,
diminished pulses of the right femoral and popliteal
arteries, and absence of pulses of the right posterior
tibialis and dorsalis pedis arteries. Computerized tomo-
graphy angiography (CTA) showed occlusion of the
lower third of the right external iliac artery, as well as
the right common femoral, superficial femoral, popli-
teal, anterior tibial, tibioperonial, peroneal and dorsalis
pedis arteries (Figure 2). Multiple collateral vessels
were seen around the right knee. He was diagnosed as
a case of vascular pythiosis and had a high-above-knee
amputation of his right leg.
Antibody to P. insidiosum was detected in a serum
sample by immunoblot and immunochromatography
tests (ICT). Fungal culture followed by nucleic sequence
analysis of 18S rRNA [9] was positive for P. insidiosum
in the resected iliac arterial tissue. The tissue histo-
pathology revealed evidence of chronic vasculitis with
granulation tissue and thrombus on the anterior tibialis
and the posterior tibialis up to the proximal margin of
femoral arteries, but the special stains failed to demon-
strate any etiologic agent, including Pythium spp.
After the surgery, the patient was given P. insidiosum
immunotherapeutic vaccine (provided by Ariya Chin-
damporn, Chulalongkorn University, Bangkok; CUH Lot
140207/15-302), as well as the antifungal drugs,
Figure 1 Ulcerated scar on the right ankle and shin.
Figure 2 Computerized tomography angiography of the lower
extremities showed occlusion of the lower third of the right
external iliac artery and its branches.
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terbinafine at a dosage of 125 mg twice daily (13 mg/kg/
day) and itraconazole at a dosage of 80 mg twice daily
(8 mg/kg/day) for 2 months. The patient remained well
and was discharged after almost 2 months after admis-
sion. Follow-up CTA performed 10 weeks after the
amputation did not reveal recurrence of the disease. At
the time of this communication, the patient has been
symptom-free for 2 years.
Conclusions
We report a case of thalassemic boy with vascular
pythiosis who was successfully treated by surgery
together with P. insidiosum immunotherapeutic vaccine
and antifungal therapy.
Many cases of human pythiosis have been reported
from Thailand [2-5]. Most cases were males between
20-60 years of age, working in agriculture [2,3]. Virtually
all vascular pythiosis patients usually present with
chronic arterial insufficiency syndrome of the lower
extremities, which varies from intermittent claudication
to gangrenous ulceration [2,3]. A history of exposure to
a swampy area prior to the illness is common. Patients
usually have underlying hematological diseases, most
frequently thalassemia or paroxysmal nocturnal hemo-
globinuria [2,3,5]. A typical vascular pythiosis has never
been reported in a pediatric patient. Our child presented
with the classical manifestations of vascular pythiosis as
seen in adult cases. However, because pediatricians were
unfamiliar with the disease, diagnosis and surgical treat-
ment were delayed. If a timely diagnosis had been made,
he could have been treated by a below-knee amputation
which is associated with a much better post-operative
function.
Culture identification of P. insidiosum is a definite
diagnostic method for pythiosis [3]. P. insidiosum can be
cultured and grows very fast in conventional nutrient
agar for fungus. An induction of the zoospore formation
is needed to confirm the identity of the organism [10].
However in cases of vascular pythiosis, the fungal cul-
ture is usually negative because viable fungus is only
present at the advancing edge of the diseased artery
which is difficult for the surgeon to obtain [1,2,4,10].
Among available serologic tests, all except the immuno-
diffusion test have high levels of sensitivity and specifi-
city. The advantage of ICT and hemagglutination over
other serological tests is that these tests are user-friendly
and rapid [11-15]. PCR amplification and identification
of the 18s rRNA gene of P. insidiosum are also useful
for organism identification in both the clinical speci-
mens and culture specimens [9,16].
Imaging studies, such as angiography and CTA,
usually demonstrate an occlusion or aneurysm in med-
ium-to-large-sized arteries of the lower extremities and
trunk. They may also appear in collateral arteries due to
the chronic course of the disease [2,3]. Histopathological
studies may reveal fungal hyphae invading the arterial
wall, with eosinophil infiltration, focal suppurative gran-
uloma, as well as a blood clot containing hyphae in the
arterial lumen [2]. Our patient presented with typical
symptoms of vascular pythiosis. Antibody to P. insidio-
sum was detected by both the ICT and immunoblot
methods. Fungal culture was positive for P. insidiosum
in the resected iliac arterial tissue. His CTA study
showed typical findings of vascular pythiosis. Although
the histopathology of the surgical tissue of our case did
not demonstrate any fungal hyphae, there was evidence
of occlusion with a blood clot in the iliac artery.
Human pythiosis has a significant morbidity and mor-
tality [2-5] because most healthcare professionals are
not familiar with this rare organism and disease. Krajae-
jun et al. found that the overall mortality rate of human
pythiosis was 29%, and increased to 40% in its vascular
form [2]. Successful management of human pythiosis
requires early recognition and appropriate treatment. In
vascular pythiosis, surgical removal of the infected
arteries, aneurysms, and surrounding tissues should be
urgently carried out. Most cases undergo limb amputa-
tion [2,3] with careful attention paid to achieving an
organism-free surgical margin. Because Pythium spp.
does not possess ergosterol in its cytoplasmic mem-
brane, conventional antifungal agents are ineffective for
treatment of human pythiosis. However, there was one
report of successful treatment of invasive facial pythiosis
with two antifungal agents, namely terbinafine plus itra-
conazole [6]. Echinocandins, the new antifungal agents
which inhibit the b-glucan synthesis of the cell wall of
P. insidiosum, may be effective in the treatment of
pythiosis [17]. An immunotherapeutic vaccine is another
treatment option and favorable outcomes have been
observed in humans [18].
In summary, human pythiosis is common in Thailand.
It has high rates of morbidity and mortality. Early recog-
nition requires the physician’s awareness of the disease,
especially in people with predisposing factors. Timely
diagnosis and prompt treatment improve the prognosis.
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